Related Experiment Videos
Prognostic usefulness of the Walter Reed staging classification for HIV infection.
K B MacDonell1, J S Chmiel, J Goldsmith
1Department of Medicine, Northwestern University Medical School, Chicago, IL 60611.
Journal of Acquired Immune Deficiency Syndromes
|January 1, 1988
Summary
The Walter Reed (WR) staging system has limited usefulness in predicting acquired immunodeficiency syndrome (AIDS) progression. Initial CD4 cell counts alone offer comparable prognostic information for HIV-positive individuals.
Area of Science:
- Immunology
- Virology
- Epidemiology
Background:
- The Walter Reed (WR) staging classification is a system used to categorize human immunodeficiency virus (HIV) infection.
- Predicting the progression of HIV to acquired immunodeficiency syndrome (AIDS) is crucial for patient management and treatment strategies.
Purpose of the Study:
- To evaluate the prognostic utility of the WR staging classification and its individual components in predicting AIDS progression.
- To compare the predictive power of the WR classification with CD4 cell counts and skin test anergy.
Main Methods:
- A prospective study was conducted on a cohort of 431 HIV-seropositive men.
- The WR classification was applied to assess its feasibility and predictive value.
- Participants were also classified based on initial CD4 cell counts and skin test results (anergy).
Main Results:
- Only 31% of the cohort could be assigned a WR stage, indicating limited applicability.
- Among those classified, only WR stage 5 showed significantly faster progression to AIDS.
- Low initial CD4 cell counts (<400 cells/mm3) were significantly associated with AIDS progression.
- CD4 cell counts alone provided prognostic information comparable to the WR classification.
- Skin test anergy predicted AIDS progression only in individuals with low CD4 counts.
Conclusions:
- The WR staging classification has limited usefulness in predicting AIDS progression due to low assignment rates.
- Initial CD4 cell counts are a more practical and equally effective prognostic marker for HIV-positive individuals.
- Skin test anergy may serve as an additional predictor in specific subgroups with compromised immune function.